Zynext Ventures
Pennington, New Jerseyzynextventures.com
Overview
Zynext Ventures is the corporate venture capital arm of Zydus Lifesciences, a global pharmaceutical company. It is a new-age venture capital firm that invests in seed, early-stage, and growth-stage disruptive healthcare technologies, including novel therapeutics, gene therapy, cell therapy, and AI in drug discovery, with the potential to fill significant unmet needs.
Portfolio Companies
4
Website
zynextventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Feldan Therapeutics | Apr 2025 | Series B | Co-investor |
| Illexcor Therapeutics | Mar 2025 | Seed | Lead |
| neuro42 | Aug 2024 | Strategic | Lead |
| Promaxo | Jul 2024 | Series B Extension | Co-investor |
| Promaxo | Mar 2024 | Early Funding | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
